CanBas Co.,Ltd. (4575)
Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| Period End | EBITDA (Million JPY) | YoY (%) |
|---|---|---|
| Jun 30, 2017 | -400 | +3.17% |
| Jun 30, 2016 | -388 | +43.13% |
| Jun 30, 2015 | -271 | -42.24% |
| Jun 30, 2014 | -469 |